Siemens Enters Field of Molecular Services for Oncology
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Siemens Healthineers will expand its portfolio with molecular testing related services and technologies for oncology and genomics
Direct comparative studies now possible with a set of cancer-specific genes for DNA from tumor tissue or for circulating tumor DNA from liquid biopsy samples
Vitrification provides excellent survivability of embryos and oocytes through the freezing process
Life science companies combine expertise to enhance transcriptome research
BioTek Instruments, Inc. presented with Scientists' Choice Award® at AACR
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
iPLEX® HS chemistry enables multiplex detection down to 1% allele frequency
New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses
RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses
Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer
Share your expertise and vote for the product that made most difference to your research in 2015
First truly end-to-end solution for next-generation sequencing receives Red Dot award
Discover SelectScience® video interviews and articles about the latest Alzheimer’s disease research methods